AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 188 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $317,000 | -75.7% | 9,670 | -65.8% | 0.00% | -100.0% |
Q3 2021 | $1,304,000 | -28.1% | 28,307 | -14.1% | 0.00% | -50.0% |
Q2 2021 | $1,814,000 | -8.2% | 32,972 | -14.0% | 0.00% | 0.0% |
Q1 2021 | $1,976,000 | +15.5% | 38,332 | -3.0% | 0.00% | 0.0% |
Q4 2020 | $1,711,000 | +20.5% | 39,533 | -2.6% | 0.00% | 0.0% |
Q3 2020 | $1,420,000 | -46.2% | 40,581 | -17.8% | 0.00% | -33.3% |
Q2 2020 | $2,641,000 | +46.6% | 49,391 | -2.8% | 0.00% | 0.0% |
Q1 2020 | $1,802,000 | -51.4% | 50,792 | -34.5% | 0.00% | -25.0% |
Q4 2019 | $3,705,000 | +71.4% | 77,598 | +16.3% | 0.00% | +33.3% |
Q3 2019 | $2,161,000 | -52.5% | 66,699 | -26.8% | 0.00% | -40.0% |
Q2 2019 | $4,546,000 | -29.6% | 91,139 | -4.8% | 0.01% | -37.5% |
Q1 2019 | $6,458,000 | -46.9% | 95,763 | -63.7% | 0.01% | -52.9% |
Q4 2018 | $12,156,000 | -54.1% | 263,616 | -23.2% | 0.02% | -43.3% |
Q3 2018 | $26,482,000 | -7.1% | 343,391 | +1.5% | 0.03% | -3.2% |
Q2 2018 | $28,499,000 | +48.3% | 338,355 | +44.0% | 0.03% | +40.9% |
Q1 2018 | $19,213,000 | +1972.6% | 234,940 | +1349.4% | 0.02% | +2100.0% |
Q4 2017 | $927,000 | +24.9% | 16,210 | +106.1% | 0.00% | 0.0% |
Q1 2015 | $742,000 | +186.5% | 7,865 | +239.6% | 0.00% | – |
Q4 2014 | $259,000 | – | 2,316 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |